Distinct roles of p42/p44^ERK and p38 MAPK in oxidant-induced AP-1 activation and cardiomyocyte hypertrophy

By Tu Victoria   Bahl Joe   Chen Qin  

Cardiovascular Toxicology, Vol. 3, Iss. 2, 2003-06 ,pp. : 119-133

Humana Press, Inc

Access to resources Recommend Favorite

Targeting p38 MAPK for the treatment of inflammatory arthritis

By Wei Shi   Siegal Gene P  

Future Rheumatology, Vol. 3, Iss. 1, 2008-02 ,pp. : 37-42

Future Medicine

Access to resources Recommend Favorite

Down-regulation of Aquaporin1 (AQP1) by peptidoglycan via p38 MAPK pathways in primary rat pleural mesothelial cells

By Liu Lihua   Du Linlin   Chen Yiqiang   Qin Shouming   Liang Qiuli   Zou Xiaoying   Liang Xiangdong   Jiang Jing   Chen Quanfang   Wang Ke   Xie Canmao  

Experimental Lung Research, Vol. 40, Iss. 4, 2014-05 ,pp. : 145-153

Informa Healthcare

Access to resources Recommend Favorite

Activation of p38 MAPK Induced by a Multi-cycle Ischaemic Preconditioning Protocol is Associated with Attenuated p38 MAPK Activity During Sustained Ischaemia and Reperfusion

By Marais E.   Genade S.   Huisamen B.   Strijdom J.G.   Moolman J.A.   Lochner A.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 4, 2001-04 ,pp. : 769-778

Academic Press

Access to resources Recommend Favorite

Decreased p38 MAPK Activity in End-Stage Failing Human Myocardium: p38 MAPK  is the Predominant Isoform Expressed in Human Heart

By Lemke L.E.   Bloem L.J.   Fouts R.   Esterman M.   Sandusky G.   Vlahos C.J.  

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 8, 2001-08 ,pp. : 1527-1540

Academic Press

Access to resources Recommend Favorite